Centene Signs Definitive Agreement to Acquire Apixio

Centene Corporation (NYSE: CNC) today announced it has signed a definitive agreement to acquire Apixio Inc., a healthcare analytics company offering Artificial Intelligence (AI) technology solutions. The transaction is subject to regulatory approvals and is expected to close by the end of 2020. Apixio provides a technology suite that mines, compiles and analyzes large volumes of disparate, unstructured patient data (such as physician notes and medical charts), and creates and refines algorithms to extract high-quality insights to support payers’ and providers’ administrative activities. Apixio’s AI platform has been trained to handle the complexities and challenges of the healthcare industry and deliver proven results.

Definitive Healthcare Expands into Medical and Scientific Expert Identification with Acquisition of Monocl

Definitive Healthcare, the leading provider of data, intelligence, and analytics on the healthcare market, announced Thursday its acquisition of Monocl, the pre-eminent subscription-based provider of medical and scientific expert data and insights. With this acquisition, Definitive Healthcare broadens its support of customers within its fast-growing life sciences segment with essential data assets and analytics designed to propel the work of Medical Affairs departments. Monocl delivers deep professional profiles on millions of experts worldwide to help companies identify and engage industry experts with the greatest knowledge, influence, and relevancy within the disease categories their drugs and therapies address.

Patients Gain Access to Clinical Notes Next Week

Starting next week, patients will have immediate access to nearly all clinical notes in their electronic health records as part of a federal mandate, although enforcement won’t happen right away. On Nov. 2, the “Information Blocking” rule of the 21st Century Cures Act, passed in 2016, will go into effect. Referred to as “Open Notes,” it states that eight types of clinical notes can’t be blocked and must be made immediately available to patients.

Medidata Acquires Digital Biomarker Business of MC10

Medidata, a Dassault Systèmes company, the global leader in creating end-to-end solutions to support the entire clinical development process, acquired the digital biomarker business of MC10. MC10’s offerings will bring novel clinical analytics and biosensor capabilities to Medidata’s existing Patient Cloud solutions in ePRO (patient-reported outcomes), eCOA (clinical outcome assessments), and biomarker discovery. This will enhance Medidata’s capabilities of integrating data from wearable sensors – including clinical grade metrics – to help customers successfully virtualize clinical trials.

RLDatix Acquires Verge Health

RLDatix, the leading global provider of intelligent patient safety solutions, announced today that it has acquired Verge Health, the recognized best-in-class credentialing software provider. This acquisition joins two leaders in the Governance, Risk, and Compliance (“GRC”) healthcare software market and will dramatically accelerate an essential shift from a reactive approach to risk management to one rooted in safety and prevention. RLDatix is the only provider that partners with healthcare delivery organizations globally to provide a comprehensive view of enterprise risk through a safety-first lens. With this acquisition, RLDatix unifies the four key pillars of GRC under one roof: Safety, Compliance, Provider Management, and Strategic Advisory Services.

Strata Decision Technology Completes Acquisition of EPSi from Allscripts

Strata Decision Technology (Strata) announced Thursday that it has finalized the acquisition of the EPSi business from Allscripts (NASDAQ: MDRX), creating the gold standard in healthcare for financial analytics, planning and performance solutions. With a combined network of over 400 health systems and 2,000 hospitals and the highest customer satisfaction ratings in the industry for over a decade, the new Strata brings a unique set of software and service solutions to help healthcare providers better analyze, plan and perform in support of caring for their community and reducing the cost of care.

WellSky® to Acquire CarePort Health from Allscripts®

WellSky, a global health and community care technology company, announced Tuesday that it has entered into a definitive agreement with Allscripts (NASDAQ: MDRX) to acquire CarePort Health (“CarePort”), a leading care coordination software company that connects acute and post-acute providers and payers. WellSky and CarePort will facilitate effective patient care transitions across the continuum — driving better outcomes for patients, providers and payers. With the addition of CarePort, WellSky is uniquely positioned to manage the acute care discharge process, track patients across post-acute care settings, apply patient and population level analytics, and support EMR-based care protocols.

Mentice to Acquire Eqip and MyIRlog™

Mentice AB (STO: MNTC) signed an agreement Thursday to acquire all assets of the Jacksonville, Florida based MedTech company Eqip, Inc., a health IT cloud services and data analytics startup. Eqip’s flagship solution, MyIRlog™, is currently being used by close to one thousand doctors across the United States for recording interventional procedure volumes and helping them establish critical credentialing requirements.

TrialCard Announces Acquisition of Canary Insights

TrialCard Incorporated announced today it has acquired Canary Insights, a Lakewood, Colorado-based healthcare information management company that provides its clients with a comprehensive subscription service for identifying and tracking changes to health plan policy and coverage information. This acquisition further strengthens TrialCard’s position as a leading provider of payer intelligence for the biopharmaceutical and medtech industries. In November 2019, TrialCard acquired Bellingham, Washington-based Policy Reporter, a healthcare technology company that also specializes in the monitoring and reporting of health plan policy intelligence. TrialCard plans to combine Canary Insights’ expertise within the medical device and diagnostics marketplace with Policy Reporter’s patented policy monitoring technology to accelerate growth within both businesses.

Curation Health Announces Series A Financing from Deerfield Management Company and WindRose Health Investors

Curation Health — creators of an advanced clinical decision support platform for value-based care — has announced completion of a Series A financing for an undisclosed amount. The round was led by Deerfield Management Company and supported by existing investor WindRose Health Investors. Curation Health will use this latest funding for strategic hires to support continued customer growth, as well as expansion of services to clients that rely on the company’s platform to successfully manage risk contracts and improve quality.